MEDICINAL cannabis distributor Leafio has announced a distribution partnership with MedReleaf Australia, whose parent company is Aurora Cannabis, a Canadian-based medical cannabis company.
The strategic partnership will expand patient access to trusted medical cannabis across Australia through Leafio's distribution network of over 4,000 pharmacies, while supporting healthcare professionals with educational resources.
Leafio will serve as a distributor of Aurora's portfolio of medical cannabis products under the MedReleaf, CraftPlant, Aurora, Whistler Cannabis Co. and IndiMed brands.
"Together, Leafio and Aurora can reach more Australian patients through trusted medical channels, bolstering access to world-class products and expertise," said Leafio GM Nicole Le Maistre.
"This partnership will deliver meaningful benefits to the region's medical cannabis industry, from enhanced research and product innovation to trusted education and improved patient outcomes."
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Dec 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Dec 25
